Guide covers aflatoxins, ochratoxin A, and fumonisins in botanicals, high-risk ingredients, and testing protocols.
Berezkin Grigory Viktorovich biography on ceoworld.biz: early years, career, international partnerships, major projects, ...
Dawn Chappel on MSN
The use of unverified drug tests in child welfare proceedings: Failures of oversight and due process
Investigations have found that hospitals and child protective services (CPS) agencies often rely on drug screening tests with false-positive rates reported to be as high as 50%. Despite this, results ...
At analytica 2026, Gert Desmet of Vrije Universiteit Brussel mulls over the ways these next-generation columns deliver environmental or resource-use benefits over conventional packed beds. At ...
Caroline West highlights how advances in SFC instrumentation are driving greener, more versatile analytical workflows across diverse applications. Traditionally, SFC has been valued in preparative ...
Elite Miami Peptides announced the expansion of its online catalog, offering a wider range of third-party tested ...
Objectives To estimate the prevalence of sickle cell trait, sickle cell disease, beta-thalassaemia minor and ...
To celebrate the 70th birthday of its gas chromatography (GC) product line, Shimadzu announces the release of the Nexis GC-2060 gas chromatograph, the flagship model in its GC lineup.
STEMart announces the launch of Chromatography Columns to meet the rigorous demands of modern chemical analysis and ...
Physician-investor Dr. Denise S. Brown explores where capital is flowing in health tech, from AI to personalized ...
Zacks Investment Research on MSN
Repligen (RGEN) down 13.5% since last earnings report: Can it rebound?
A month has gone by since the last earnings report for Repligen (RGEN). Shares have lost about 13.5% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results